Time for a paradigm shift? Making the case for tailored selection of antiplatelet therapy.
Sign Up to like & getrecommendations! Published in 2022 at "European heart journal"
DOI: 10.1093/eurheartj/ehac046
Abstract: to Comparative effects of guided vs. potent P2Y 12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials read more here.
Keywords: case tailored; making case; therapy; paradigm shift ... See more keywords